Education
About Us
Working with TipRanks
Follow Us
BrainAurora Medical Technology Limited (HK:6681)
:6681
6681 Stock Chart & Stats
HK$8.22
--
Market closed
HK$8.22
--
Day’s Range― - ―
52-Week RangeHK$3.13 - HK$17.79
Previous CloseN/A
VolumeN/A
Average Volume (3M)23.54M
Market Cap
HK$8.13B
Enterprise ValueHK$7.48B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.21
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,266,278,000
10 Day Avg. Volume9,658,200
30 Day Avg. Volume23,541,890
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-8.21
Price to Sales (P/S)40.60
P/FCF Ratio-17.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.1
Revenue Forecast (FY)HK$264.20M
BrainAurora Medical Technology Limited News
6681 FAQ
What was BrainAurora Medical Technology Limited’s price range in the past 12 months?
BrainAurora Medical Technology Limited lowest stock price was HK$3.13 and its highest was HK$17.79 in the past 12 months.
What is BrainAurora Medical Technology Limited’s market cap?
BrainAurora Medical Technology Limited’s market cap is HK$8.13B.
When is BrainAurora Medical Technology Limited’s upcoming earnings report date?
BrainAurora Medical Technology Limited’s upcoming earnings report date is Aug 28, 2025 which is 73 days ago.
How were BrainAurora Medical Technology Limited’s earnings last quarter?
Currently, no data Available
Is BrainAurora Medical Technology Limited overvalued?
According to Wall Street analysts BrainAurora Medical Technology Limited’s price is currently Overvalued.
Does BrainAurora Medical Technology Limited pay dividends?
BrainAurora Medical Technology Limited does not currently pay dividends.
What is BrainAurora Medical Technology Limited’s EPS estimate?
BrainAurora Medical Technology Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BrainAurora Medical Technology Limited have?
BrainAurora Medical Technology Limited has 1,266,278,000 shares outstanding.
What happened to BrainAurora Medical Technology Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of BrainAurora Medical Technology Limited?
Currently, no hedge funds are holding shares in HK:6681
Company Description
BrainAurora Medical Technology Limited
BrainAurora Medical Technology Limited develops medical-grade digital therapy (DTx) products for cognitive impairment. The company offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. It develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Cognitive Ability Testing software; the Cognitive Ability Supplemental Screening and Assessment software; and the Dyslexia Supplemental Screening and Assessment software. The company was founded in 2012 and is based in Shaoxing, China.
Technical Analysis
JBM (Healthcare) Ltd.
―
MicroPort NeuroTech Limited
―
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
―
Shanghai Conant Optical Co. Ltd. Class H
―
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
―